Ensysce Biosciences, Inc.ENSCNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P3
Near historical low
vs 3Y Ago
-1.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -64.04% |
| Q2 2025 | 3.90% |
| Q1 2025 | 1.25% |
| Q4 2024 | -61.87% |
| Q3 2024 | 1780.59% |
| Q2 2024 | -40.54% |
| Q1 2024 | -40.64% |
| Q4 2023 | 18.29% |
| Q3 2023 | -11.23% |
| Q2 2023 | -37.89% |
| Q1 2023 | -44.91% |
| Q4 2022 | 413.14% |
| Q3 2022 | 34.65% |
| Q2 2022 | -65.60% |
| Q1 2022 | -63.12% |
| Q4 2021 | 36.18% |
| Q3 2021 | 170.14% |
| Q2 2021 | 77.40% |
| Q1 2021 | -39.84% |
| Q4 2020 | -49.68% |
| Q3 2020 | -54.64% |
| Q2 2020 | 111.58% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |